Oncopeptides
Organisation
Trials
Phase 3, Terminated, 54 people, 2 Dec 2020
Phase 2, Terminated, 27 people, 2 Jun 2020
Phase 1, Terminated, 6 people, 4 Oct 2019
Phase 2, Terminated, 35 people, 21 Aug 2018
Phase 1/2, Terminated, 56 people, 29 Mar 2018
Phase 3, Terminated, 495 people, 12 May 2017
Phase 2, Completed, 157 people, 15 Nov 2016
Phase 1/2, Terminated, 75 people, 12 Jul 2013
Named in competing interests
Fees or honoraria, Grants or research support, 1 Apr 2026
Sources: pubmed.ncbi.nlm.nih.gov